Related Articles by Review for PMID: 17873882

Year	Number of Results
2004	1
2005	1
2007	1
2008	2
2009	3
2010	1
2011	5
2012	2
2013	1
2014	1
2015	1
2016	2
2018	2
2019	1
2020	2
2024	0

1

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.

Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, Cordon-Cardo C, Parsons R, Zúñiga-Pflücker JC, Dominguez M, Ferrando AA. Palomero T, et al. Nat Med. 2007 Oct;13(10):1203-10. doi: 10.1038/nm1636. Epub 2007 Sep 16. Nat Med. 2007. PMID: 17873882 Free PMC article.

2

The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.

Mendes RD, Canté-Barrett K, Pieters R, Meijerink JP. Mendes RD, et al. Haematologica. 2016 Sep;101(9):1010-7. doi: 10.3324/haematol.2016.146381. Haematologica. 2016. PMID: 27582570 Free PMC article. Review.

3

New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.

Hales EC, Taub JW, Matherly LH. Hales EC, et al. Cell Signal. 2014 Jan;26(1):149-61. doi: 10.1016/j.cellsig.2013.09.021. Epub 2013 Oct 16. Cell Signal. 2014. PMID: 24140475 Review.

4

NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.

Guo D, Teng Q, Ji C. Guo D, et al. Leuk Lymphoma. 2011 Jul;52(7):1200-10. doi: 10.3109/10428194.2011.564696. Epub 2011 Apr 4. Leuk Lymphoma. 2011. PMID: 21463127 Review.

5

Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas.

Palomero T, Ferrando A. Palomero T, et al. Clin Cancer Res. 2008 Sep 1;14(17):5314-7. doi: 10.1158/1078-0432.CCR-07-4864. Clin Cancer Res. 2008. PMID: 18765521 Free PMC article. Review.

6

Recent advances on NOTCH signaling in T-ALL.

Tzoneva G, Ferrando AA. Tzoneva G, et al. Curr Top Microbiol Immunol. 2012;360:163-82. doi: 10.1007/82_2012_232. Curr Top Microbiol Immunol. 2012. PMID: 22673746 Review.

7

The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.

Barata JT. Barata JT. Adv Enzyme Regul. 2011;51(1):37-49. doi: 10.1016/j.advenzreg.2010.09.012. Epub 2010 Oct 28. Adv Enzyme Regul. 2011. PMID: 21035501 Review.

8

Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).

Hafsi S, Pezzino FM, Candido S, Ligresti G, Spandidos DA, Soua Z, McCubrey JA, Travali S, Libra M. Hafsi S, et al. Int J Oncol. 2012 Mar;40(3):639-44. doi: 10.3892/ijo.2011.1312. Epub 2011 Dec 20. Int J Oncol. 2012. PMID: 22200790 Review.

9

The role of NOTCH1 signaling in T-ALL.

Ferrando AA. Ferrando AA. Hematology Am Soc Hematol Educ Program. 2009:353-61. doi: 10.1182/asheducation-2009.1.353. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008221 Free PMC article. Review.

10

Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia.

Palomero T, Ferrando A. Palomero T, et al. Clin Lymphoma Myeloma. 2009;9 Suppl 3(Suppl 3):S205-10. doi: 10.3816/CLM.2009.s.013. Clin Lymphoma Myeloma. 2009. PMID: 19778842 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year